Latest Leadership News

Saunders International appoints Angelo De Angelis as CEO effective October 2025, succeeding Mark Benson who will support the transition through 2026. This leadership change signals a steady hand guiding the company’s next growth phase.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.

Altamin Limited has announced a $6.46 million capital raising via a pro rata entitlement offer to fund development of its lithium-potash Lazio Project and zinc-lead Gorno Project in Italy. The majority shareholder Victor Smorgon Group has committed strongly, underpinning the raise.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

Hastings Technology Metals and Wyloo have formalised their joint venture for the Yangibana Rare Earths Project, with Wyloo taking a 60% stake and cancelling A$123 million in exchangeable notes, significantly de-risking the project and reducing Hastings’ funding burden.

Core Energy Minerals has appointed Anthony Greenaway as Managing Director, aiming to leverage his extensive exploration expertise to advance its uranium and rare earth projects in South Australia and Brazil.

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Peel Mining has appointed a new leadership team with deep mining and capital markets expertise, aiming to unlock significant value from its copper and polymetallic assets in the prolific Cobar region. The company signals a strategic shift towards targeted exploration, regional consolidation, and disciplined growth.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Ardea Resources has completed a major infill drilling campaign at its Goongarrie South deposit, confirming premium nickel-cobalt-scandium mineralisation that underpins its Definitive Feasibility Study. The results reinforce the project’s position as Australia’s largest nickel-cobalt resource.

Viva Energy announces the resignation of Jevan Bouzo as CEO of its Convenience and Mobility business, appointing Jennifer Gray as interim leader while searching for a permanent replacement.

XPON Technologies announces a significant leadership reshuffle with founder Matt Forman stepping down as CEO due to health reasons, while Mark Simari assumes the role of Executive Chair amid strategic growth initiatives.